Cite
Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group
MLA
Hobbs, Nicola Z., et al. “Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group.” Journal of Huntington’s Disease, no. Preprints, Jan. 2024, pp. 1–37. EBSCOhost, https://doi.org/10.3233/JHD-240016.
APA
Hobbs, N. Z., Papoutsi, M., Delva, A., Kinnunen, K. M., Nakajima, M., Van Laere, K., Vandenberghe, W., Herath, P., & Scahill, R. I. (2024). Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group. Journal of Huntington’s Disease, Preprints, 1–37. https://doi.org/10.3233/JHD-240016
Chicago
Hobbs, Nicola Z., Marina Papoutsi, Aline Delva, Kirsi M. Kinnunen, Mitsuko Nakajima, Koen Van Laere, Wim Vandenberghe, Priyantha Herath, and Rachael I. Scahill. 2024. “Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group.” Journal of Huntington’s Disease, no. Preprints (January): 1–37. doi:10.3233/JHD-240016.